Get started
Author

Hsuan‐Jen Shih

Observed names: HSUAN-JEN SHIH, Hsuan-Jen Shih
ORCID: 0009-0000-3877-2258
Observed ORCID: 0009-0000-3877-2258
OpenAlex ID: A5113857050
BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
2025 · Wojciech Jurczak, Michal Kwiatek, et al. · Journal of Clinical Oncology · 16
PDF
Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model
2020 · Yi-Ru Pan, Chiao-En Wu, et al. · Vaccines · 9
PDF
Preliminary Results of a Phase 2a Dose Optimization Study of ASLAN003 (DHODH inhibitor) in Acute Myeloid Leukemia (AML) Patients Who Are Ineligible for Standard Therapy; Early Signs of Activity
2018 · Stephen B Ting, Chin Hin Ng, et al. · Blood · 8
Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma
2023 · Ning-Chun Chen, Hung Chang, et al. · Clinical and Experimental Medicine · 6
Systemic Anticoagulation and Inpatient Outcomes of Pancreatic Cancer: Real-World Evidence from U.S. Nationwide Inpatient Sample
2023 · Yen-Min Huang, Hsuan-Jen Shih, et al. · Cancers · 6
PDF
Chronic lymphocytic leukemia presenting with ascites diagnosed by clonality analysis via gene rearrangement assay: A case report
2014 · YEN-MIN HUANG, LEE-YUNG SHIH, et al. · Oncology Letters · 5
PDF
Clinical Features of Testicular Lymphoma
2013 · Hsuan-Jen Shih, Lee-Yung Shih, et al. · Acta Haematologica · 5
Pirtobrutinib vs bendamustine plus rituximab (BR) in patients with CLL/SLL: First results from a randomized phase III study Examining a non-covalent BTK inhibitor in untreated patients
2025 · Wojciech Jurczak, Michal Kwiatek, et al. · Blood · 4
PDF
Prognostic impact of pre-treatment and post-treatment plasma Epstein-Barr virus DNA in peripheral T-cell lymphomas
2025 · Chu-Yi Chan, Tung-Liang Lin, et al. · Annals of Medicine · 3
Major impact of prognosis by age and sex in patients with primary mediastinal large B‑cell lymphoma
2023 · Hsuan-Jen Shih, Ming-Chung Kuo, et al. · Oncology Letters · 3
PDF
Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report
2022 · Zi-Wei Chen, Gigin Lin, et al. · International Journal of Molecular Sciences · 1
PDF
A multicenter, phase Ib/2 study of varlitinib plus gemcitabine and cisplatin (gem/cis) for treatment of naïve, advanced, or metastatic biliary tract cancer (BTC).
2019 · Do-Youn Oh, Wei-Peng Yong, et al. · Journal of Clinical Oncology · 1
Clonal Leukemic Evolution In Myelodysplastic Syndromes With ASXL1 and EZH2 mutations: A Comparative Analysis Of 58 Paired Samples
2013 · Hsuan-Jen Shih, Lee-Yung Shih, et al. · Blood · 1
Favorable Outcome of Intensive Treatment for Relapsed Diffuse Large B Cell Lymphoma With Secondary Central Nervous System Involvement
2026 · HUNG CHANG, MING-CHUNG KUO, et al. · Anticancer Research
β2-microglobulin is superior to lactate dehydrogenase and bulky disease for risk stratification in diffuse large B-cell lymphoma patients with IPI 1–2
2026 · Hung Chang, Yu-Shin Hung, et al. · Annals of Hematology
Long‐Term Anticoagulation and Outcomes of Head and Neck Cancer: Analysis of the US Nationwide Inpatient Sample
2025 · Chun‐Feng Wu, Hang Huong Ling, et al. · Clinical and Experimental Pharmacology and Physiology
Identification of factors associated with a high success rate of treatment-free remission in chronic myeloid leukemia: A multicenter study in Taiwan
2025 · Ning-Chun Chen, Ming-Chung Kuo, et al. · Blood
PDF
Efficacy of Wee1 G2 Checkpoint Kinase and Mouse Double Minute 2 Homolog Inhibitors in Gastrointestinal Stromal Tumors Determined by p53 Status
2025 · Chiao-Ping Chen, Yan-Jei Tang, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Correction: Huang et al. Systemic Anticoagulation and Inpatient Outcomes of Pancreatic Cancer: Real-World Evidence from U.S. Nationwide Inpatient Sample. Cancers 2023, 15, 1985
2024 · Yen-Min Huang, Hsuan-Jen Shih, et al. · Cancers
PDF
P1519: Multicenter Study of Sars-cov-2 Infection in Patients With Hematological Disease: Vaccination, Antiviral Therapy, Risk Factors, and Outcomes in Taiwan
2023 · Huai-Chueh Gem Wu, Ling-Jung Chiu, et al. · HemaSphere
AB063. P-34. A multicenter, phase 1b/2 study of varlitinib plus gemcitabine and cisplatin (gem/cis) for treatment naïve advanced or metastatic biliary tract cancer (BTC)
2019 · Do-Youn Oh, Wei-Peng Yong, et al. · HepatoBiliary Surgery and Nutrition
Works count: 21
Citation count: 68
H-index: 5
I10-index: 1
Year
Topic
Type